Transfusion Complications Monitoring Publications

Peer-reviewed Articles

2022

• Patterson S, Singleton A, Branscomb J, Nsonwu V, Spratling R. Transfusion complications in thalassemia: patient knowledge and perspectivesexternal icon.  Frontiers in Medicine, Hematology. 2022; 9:772886.

2021

• Lal A, Wong T, Keel S, et al. The transfusion management of beta thalassemia in the United Statesexternal icon. Transfusion. 2021;61(10):3027-3039. doi:10.1111/trf.16640
• Mensah C, Sheth S. Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia.external icon Hematology Am Soc Hematol Educ Program. 2021;2021(1):607-613. doi:10.1182/hematology.2021000296
• Rollins MR, Boudreaux J, Eckman J, Branscomb J, Zhou M, Snyder A. Intermittent transfusions for treatment of thalassemia in the state of Georgia, 2007-2016external icon. Annals of Hematology and Oncology. 2021; 8(4): 1340.

2020

• Lawrence RH, Singleton A, Branscomb J. Blood Transfusion: Knowledge, Perspectives, and Experience of Individuals With Sickle Cell Diseaseexternal icon. Journal of Patient Experience. 2020 Sep 10.

2019

• Mainous AG, III, Rooks B, Tanner RJ, Carek PJ, Black V, Coates TD. Shared Care for Adults with Sickle Cell Disease: An Analysis of Care from Eight Health Systemsexternal icon. Journal of Clinical Medicine. 2019; 8(8):1154.
• Tang A, Branscomb J, Zhou M, Snyder A, Eckman, J. Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell diseaseexternal icon. Pediatr Blood Cancer. 2019;e27921. doi: 10.1002/pbc.27921
• Fasano RM, Branscomb J, Lane PA, Josephson CD, Snyder AB, Eckman JR. Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemiaexternal icon Transfus Med. 2019 Feb 10.
• Spratling R, Lawrence RH. Facilitators and Barriers to Minority Blood Donations: A Systematic Reviewexternal icon Nurs Res. 2019 Mar 1. [Epub ahead of print]
• Yee MEM, Meyer EK, Fasano, RM, Lane PA, Josephson CD, Brega AG. Health literacy and knowledge of chronic transfusion therapy in adolescents with sickle cell disease and caregiversexternal icon. Pediatr Blood Cancer. 2019 Apr [Epub ahead of print]

2018

• Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, et al. Transfusion practices and complications in thalassemiaexternal icon. Transfusion 2018 Sep 27. [Epub ahead of print]

• Singleton A, Spratling R. A strategic planning tool for increasing African American blood donationexternal icon. Health Promot Pract. 2018 May. [Epub ahead of print]

• Mainous AG 3rd, Carek PJ, Lynch K, Tanner RJ, Hulihan MM, Baskin J, et al. Effectiveness of clinical decision support based intervention in the improvement of care for adult sickle cell disease patients in primary careexternal icon. J Am Board Fam Med. 2018;31(5):812-816.

• Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: A systematic review.external icon Transfus Med Rev. 2018 Jul 26. [Epub ahead of print]

• Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, et al. Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapyexternal icon. Transfusion 2018;58(6):1363-1371.

2017

• Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, et al. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemiaexternal icon. Transfusion 2017;57(11):2738-2746.

Briefs/Reports

Lessons Learned from Attempted Implementation of a Patient Antibody Registry in Georgiaexternal icon

Using Mobile Apps to Reduce Transfusion Complicationsexternal icon